Minerva Respiratory Medicine

Scope & Guideline

Unveiling breakthroughs in respiratory medicine.

Introduction

Delve into the academic richness of Minerva Respiratory Medicine with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageMulti-Language
ISSN2784-8477
PublisherEDIZIONI MINERVA MEDICA
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 2021 to 2024
AbbreviationMINERVA RESPIR MED / Minerva Respir. Med.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY

Aims and Scopes

Minerva Respiratory Medicine is dedicated to advancing the field of respiratory health through comprehensive research and clinical studies. The journal focuses on a wide range of topics within pulmonary medicine, emphasizing innovative methodologies and interdisciplinary approaches.
  1. Chronic Respiratory Diseases:
    The journal extensively covers chronic conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, examining their management, treatment outcomes, and the impact of comorbidities.
  2. Infectious Respiratory Diseases:
    A significant focus is placed on infectious diseases affecting the respiratory system, including COVID-19, tuberculosis, and pneumonia, with an emphasis on epidemiology, clinical features, and treatment strategies.
  3. Interventional Pulmonology:
    Research on interventional techniques such as bronchoscopy and endoscopic procedures is a core area, highlighting advancements in diagnostic and therapeutic approaches.
  4. Respiratory Rehabilitation and Patient Quality of Life:
    The journal explores the role of rehabilitation programs and their effectiveness on patient outcomes, particularly in chronic respiratory conditions and post-viral syndromes.
  5. Emerging Technologies in Respiratory Medicine:
    There is a consistent focus on the integration of new technologies, including machine learning, telemedicine, and non-invasive ventilation strategies, to improve diagnosis and treatment.
Recent publications in Minerva Respiratory Medicine reveal a dynamic shift towards several trending and emerging themes that reflect current challenges and advancements in respiratory health.
  1. Impact of COVID-19 on Respiratory Health:
    A prominent trend is the exploration of COVID-19's implications for patients with existing respiratory conditions, including long-term sequelae and management strategies.
  2. Advancements in Telemedicine and Remote Monitoring:
    The journal shows increasing interest in telemedicine, particularly in the context of managing chronic respiratory diseases and enhancing patient engagement during the pandemic.
  3. Personalized and Targeted Therapies:
    Research focusing on personalized medicine, including biomarker-driven therapies and patient-specific treatment plans, is emerging as a significant theme in the journal.
  4. Interdisciplinary Approaches to Respiratory Care:
    There is a growing trend towards collaborative studies that integrate various medical specialties to address complex respiratory issues, enhancing holistic patient care.
  5. Role of Artificial Intelligence in Respiratory Medicine:
    The integration of artificial intelligence and machine learning into respiratory diagnostics and treatment is becoming increasingly prominent, reflecting technological advancements in the field.

Declining or Waning

While Minerva Respiratory Medicine continues to thrive in many areas, certain themes have shown a decline in focus over recent years. These waning scopes reflect shifting priorities and emerging challenges in the field.
  1. Traditional Pharmacological Approaches:
    There appears to be a declining emphasis on conventional pharmacological treatments for respiratory diseases, as the journal increasingly highlights novel therapies and personalized medicine.
  2. Basic Research on Lung Physiology:
    Research specifically focused on fundamental aspects of lung physiology seems to be less frequently published, possibly overshadowed by clinical and translational studies.
  3. Environmental and Occupational Lung Diseases:
    There has been a noticeable reduction in articles addressing environmental and occupational factors affecting lung health, indicating a potential shift towards more acute and infectious respiratory conditions.

Similar Journals

Egyptian Journal of Bronchology

Fostering collaboration in the fight against bronchial diseases.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Egyptian Journal of Chest Diseases and Tuberculosis

Transforming knowledge into practice for better respiratory care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

Respiratory Investigation

Transforming insights into impactful respiratory solutions.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

BMJ Open Respiratory Research

Shaping the future of respiratory care with open access insights.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.

Tuberkuloz ve Toraks-Tuberculosis and Thorax

Fostering dialogue on thoracic health challenges.
Publisher: TURKISH ASSOC TUBERCULOSIS & THORAXISSN: 0494-1373Frequency: 4 issues/year

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Innovating Clinical Insights for Better Patient Outcomes
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Annals of Thoracic Medicine

Elevating patient care through groundbreaking research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Annals of the American Thoracic Society

Empowering professionals with the latest in thoracic science.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

RESPIRATION

Exploring Innovations in Respiratory Research
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

RESPIROLOGY

Fostering Excellence in Pulmonary Studies
Publisher: WILEYISSN: 1323-7799Frequency: 12 issues/year

RESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.